Section Arrow
FLGT.NASDAQ
- Fulgent Genetics
Quotes are at least 15-min delayed:2025/07/02 23:06 EDT
Last
 20.1
+0.19 (+0.95%)
Day High 
20.19 
Prev. Close
19.91 
1-M High
22.115 
Volume 
229.54K 
Bid
19.87
Ask
20.4
Day Low
19.68 
Open
19.94 
1-M Low
19.01 
Market Cap 
606.13M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 19.76 
20-SMA 20.51 
50-SMA 19.95 
52-W High 25.11 
52-W Low 14.57 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.33/-0.39
Enterprise Value
612.74M
Balance Sheet
Book Value Per Share
37.03
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
283.47M
Operating Revenue Per Share
9.41
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NEOGNeogen Corp5.23+0.15+2.95%879PE
BIAFbioAffinity Technologies0.29+0.0265+10.06%-- 
DHRDanaher Corp202.5+1.4+0.70%38.97PE
OPKOPKO Health1.34+0.01+0.75%-- 
TMOThermo Fisher Scientific427.76+6.29+1.49%24.72PE
Quotes are at least 15-min delayed:2025/07/02 23:06 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.